baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

INSULIN GLARGINE

Pharmaceutical form: solution for injection Route of administration: sub-cutaneous Dose regimen: once a day at bedtime

DRUG

INSULIN GLULISINE

Pharmaceutical form: solution for injection Route of administration: sub-cutaneous Dose regimen: three times a day, preferably just before the meal

Trial Locations (43)

1006

Investigational Site Number 78803, Tunis

4091

Investigational Site Number 12464, Durban

Investigational Site Number 12465, Durban

Investigational Site Number 710001, Durban

Investigational Site Number 710002, Durban

6000

Investigational Site Number 12484, Port Elizabeth

Investigational Site Number 710003, Port Elizabeth

9301

Investigational Site Number 12466, Bloemfontein

Investigational Site Number 710006, Bloemfontein

11415

Investigational Site Number 1, Riyadh

44600

Investigational Site Number 48401, Guadalajara

44656

Investigational Site Number 48402, Guadalajara

44680

Investigational Site Number 48404, Guadalajara

64460

Investigational Site Number 48403, Monterrey

Unknown

Investigational Site Number 01201, Algeries

Investigational Site Number 01202, Algiers

Investigational Site Number 01203, Algiers

Investigational Site Number 01204, Algiers

Investigational Site Number 03201, Caba

Investigational Site Number 03202, Caba

Investigational Site Number 03203, Caba

Investigational Site Number 03204, Caba

Investigational Site Number 03205, Morón

Investigational Site Number 17003, Barranquilla

Investigational Site Number 17004, Bogotá

Investigational Site Number 17005, Bogotá

Investigational Site Number 17007, Bogotá

Investigational Site Number 17006, Medellín

Investigational Site Number 01, Kuwait City

Investigational Site Number 12468, Benoni

Investigational Site Number 710004, Benoni

Investigational Site Number 12467, Pretoria

Investigational Site Number 710005, Pretoria

Investigational Site Number 78801, Sfax

Investigational Site Number 78805, Sfax

Investigational Site Number 78802, Tunis

Investigational Site Number 78804, Tunis

80540-010

Investigational Site Number 076-007, Curitiba

71625-009

Investigational Site Number 076-003, Distrito Federal

60430-370

Investigational Site Number 076-010, Fortaleza

17519-101

Investigational Site Number 076-006, Marília

91350-250

Investigational Site Number 076-004, Porto Alegre

01244-030

Investigational Site Number 076-002, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01204593 - baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter